Clonidine Transdermal System Usp, 0.3 Mg/day Patch
Product Images NDC 52817-507

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Clonidine Transdermal System Usp, 0.3 Mg/day (NDC 52817-507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (0.1 mg)

Packaging label for Clonidine Transdermal System USP 0.1 mg/day by TruPharma, LLC. The label indicates a patch dosage form with 4 systems and 4 adhesive covers per package. The text advises prescription use and transdermal administration, with a note about removing the patch before MRI procedures. The NDC code is partially visible as 52817-505-04.*

FDA Label Image

Carton (0.2 mg)

Packaging label for Clonidine Transdermal System USP 0.2 mg/day patch by TruPharma, LLC. The label shows the product name and strength prominently, indicating a package containing 4 systems and 4 adhesive covers for transdermal use. It includes usage notes about programmed delivery, a barcode, and the labeler information.*

FDA Label Image

Carton (0.3 mg)

Packaging label for Clonidine Transdermal System USP 0.3 mg/day patch by TruPharma, LLC. The label indicates a package containing 4 systems and 4 adhesive covers. It includes instructions specifying transdermal use only, with a dosage of 0.3 mg clonidine delivered per day over one week. The label also displays the NDC 52817-507-04 and notes to remove the patch prior to MRI procedures.*

FDA Label Image

Figure 1 (Figure 1)

An instructional illustration showing application of the Clonidine Transdermal System USP 0.2 mg/day patch on the upper arm. The diagram points to the patch placement site and notes the optional adhesive cover to be applied over the patch if necessary.*

FDA Label Image

Figure 2 Left (Figure 2a)

Clonidine Transdermal System USP 0.1 mg/day patch packaging label from TruPharma, LLC. The label indicates the patch delivers 0.1 mg per day of clonidine transdermally. It includes usage warnings such as avoiding burns and MRI exposure warnings. The label is monochrome with black text on a white background.*

FDA Label Image

Figure 2 Right (Figure 2b)

The image shows a packaging label for an adhesive cover labeled for use with the Clonidine Transdermal System USP, 0.2 mg/day patch. The label includes a warning that the adhesive cover does not contain active medication and instructs to apply it over the patch if necessary. It also notes that suggestions for use are found in the patient information sheet.*

FDA Label Image

Figure 3 (Figure 3)

An illustration showing hands peeling back the protective packaging of a Clonidine Transdermal System USP patch labeled 0.2 mg/day. The diagram visually demonstrates how to open the patch pouch before application.*

FDA Label Image

Figure 4 (Figure 4)

An instructional illustration showing two hands peeling apart a transdermal patch, demonstrating proper handling or application technique of a patch-based medication.*

FDA Label Image

Figure 5 (Figure 5)

An illustration showing a hand applying a patch to the upper arm area, demonstrating the placement of a transdermal system patch on the skin.*

FDA Label Image

Figure 6 (Figure 6)

Packaging label for Clonidine Transdermal System USP 0.2 mg/day showing an adhesive cover. The label warns that the cover does not contain active medication and advises applying it over the patch if necessary. It also notes that suggestions for use appear in the patient information sheet. The label emphasizes its use as a transdermal patch component by TruPharma, LLC.*

FDA Label Image

Pouch (back) (0.1 mg)

Packaging label for Clonidine Transdermal System USP 0.2 mg/day patch shows a single-use pouch containing one patch with medication. Instructions include removing the clear backing before use and storing at 20°C to 25°C (68°F to 77°F). The label also indicates distribution by TruPharma LLC, Tampa, FL.*

FDA Label Image

Pouch (front) (0.1 mg)

Label of Clonidine Transdermal System USP, 0.1 mg/day patch by TruPharma, LLC. The label notes a new appearance and states programmed delivery of 0.1 mg clonidine per day for one week. It includes a caution to remove the patch before MRI to avoid burns and is marked for prescription use only.*

FDA Label Image

Pouch (back) (0.2 mg)

Packaging label for Clonidine Transdermal System USP 0.2 mg/day patch, distributed by TruPharma LLC. The label includes instructions to remove clear backing before use, store between 20°C to 25°C (68°F to 77°F), and a barcode.*

FDA Label Image

Pouch (front) (0.2 mg)

Label of Clonidine Transdermal System USP 0.2 mg/day patch from TruPharma, LLC. The label highlights the programmed delivery of 0.2 mg clonidine per day for one week. It includes a warning to remove the patch before MRI procedures to avoid burns. The label also features a note about new appearance and a prescription-only designation.*

FDA Label Image

Pouch (back) (0.3 mg)

Label of a pouch for Clonidine Transdermal System USP, 0.2 mg/day patch, distributed by TruPharma LLC. The label includes a barcode, instructions to remove the pouch and the clear backing before use, and storage conditions specifying 20°C to 25°C (68°F to 77°F). The pouch contains one system with medication.*

FDA Label Image

Pouch (front) (0.3 mg)

Label for Clonidine Transdermal System USP, 0.3 mg/day patch by TruPharma, LLC. The label highlights the 0.3 mg/day strength and mentions programmed delivery of clonidine for one week. It includes a caution to remove the patch before an MRI procedure to avoid burns.*

FDA Label Image

Clonidine Structure (Clonidine Structure)

Chemical structure of clonidine, the active ingredient in Clonidine Transdermal System USP 0.2 mg/day. The structure depicts a chlorinated aromatic ring attached to an imidazoline ring.*

FDA Label Image

Company Logo (Company Logo 2)

FDA Label Image

Company Logo (Company Logo 3)

FDA Label Image

Company Logo (Company Logo)

FDA Label Image

Adhesive-cover (0.1 mg)

Packaging label for Clonidine Transdermal System USP 0.2 mg/day patch by TruPharma, LLC showing an adhesive cover. The label states that the adhesive cover does not contain active medication and should be applied over the patch if necessary, with usage suggestions referred to the patient information sheet.*

FDA Label Image

Adhesive Cover (0.2 mg)

Text panel stating the contents include one adhesive cover. It warns that the cover does not contain active medication and should be applied over the patch if necessary. It advises that suggestions for use are in the patient information sheet.*

FDA Label Image

Adhesive Cover (0.3 mg)

This image shows a text panel from a Clonidine Transdermal System package, indicating it contains 1 adhesive cover. It includes a warning that the adhesive cover does not contain active medication and should be applied over the patch if necessary. Suggestions for use are noted to be in the patient information sheet.*

FDA Label Image

Cross-section-table (Cross Section Table)

An instructional diagram showing the layers of a Clonidine Transdermal System patch. The labeled layers from top to bottom are: Backing, Drug Reservoir, Control Membrane, Adhesive, and Slit Release Liner, illustrating the patch's multi-layer composition for transdermal drug delivery.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.